Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors

Pulmonary hypertension (PH) is common in patients with heart failure with preserved ejection fraction (HFpEF). A chronic increase in mean left atrial pressure leads to passive remodeling in pulmonary veins and capillaries and modest PH (isolated postcapillary PH, Ipc-PH) and is not associated with s...

Full description

Bibliographic Details
Main Authors: Artem Ovchinnikov, Alexandra Potekhina, Evgeny Belyavskiy, Fail Ageev
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Pharmaceuticals
Subjects:
phosphodiesterase
PDE inhibitors
pulmonary hypertension
heart failure with preserved ejection fraction
diastolic dysfunction
Online Access:https://www.mdpi.com/1424-8247/15/8/1024

Internet

https://www.mdpi.com/1424-8247/15/8/1024

Similar Items